Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on May 17, 2010 9:36am
228 Views
Post# 17104866

market depth

market depthI continue to watch market depth, more than I should, and I see investors trying to accumulate shares. Its clear that they are not yet aggressive and doing it on their terms. I continue to be amazed that shares are handed to them at these levels. At times the bids are in and out throughout the day trying to frustrate sellers. We should be sitting at 52 week highs at this point which is still a bargain, with whats on deck. (at the same point if these buyers take a break we will continue to see no push)
     I am still looking for $2.00 by the end of the month and frustrated that I was unable to add because my wife has had enough with Diagnocure.

     My drivers for this move are simple; trial is completed, a # of trials/posters will be discussed at the upcoming meeting and U.S. hospitals are adopting the PCA3 test prior to FDA approval.
Bullboard Posts